Nothing Special   »   [go: up one dir, main page]

USD408917S - Membrane support structure of a flow through cell for blood gas measurement - Google Patents

Membrane support structure of a flow through cell for blood gas measurement Download PDF

Info

Publication number
USD408917S
USD408917S US29/084,200 US8420098F USD408917S US D408917 S USD408917 S US D408917S US 8420098 F US8420098 F US 8420098F US D408917 S USD408917 S US D408917S
Authority
US
United States
Prior art keywords
flow
cell
support structure
membrane support
blood gas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/084,200
Inventor
Thomas G. Hacker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Cardiovascular Systems Corp
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Priority to US29/084,200 priority Critical patent/USD408917S/en
Assigned to MINNESOTA MINING AND MANUFACTURING COMPANY reassignment MINNESOTA MINING AND MANUFACTURING COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HACKER, THOMAS G.
Application granted granted Critical
Publication of USD408917S publication Critical patent/USD408917S/en
Assigned to TERUMO CARDIOVASCULAR SYSTEMS CORPORATION reassignment TERUMO CARDIOVASCULAR SYSTEMS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MINNESOTA MINING & MANUFACTURING COMPANY
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Description

FIG. 1 is a first perspective view of a membrane support structure of a flow through cell for blood gas measurement showing my new design, the broken line showing of the flow through passage is for illustrative purposes only and forms no part of the claimed design.
FIG. 2 is a second perspective view thereof;
FIG. 3 is a top view thereof;
FIG. 4 is a left side view thereof, the right side view being a mirror image thereof;
FIG. 5 is a bottom view thereof; and,
FIG. 6 is a first end view thereof, the second end view being a mirror image thereof.

Claims (1)

  1. The ornamental design for a membrane support structure of a flow through cell for blood gas measurement, as shown and described.
US29/084,200 1998-02-26 1998-02-26 Membrane support structure of a flow through cell for blood gas measurement Expired - Lifetime USD408917S (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/084,200 USD408917S (en) 1998-02-26 1998-02-26 Membrane support structure of a flow through cell for blood gas measurement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/084,200 USD408917S (en) 1998-02-26 1998-02-26 Membrane support structure of a flow through cell for blood gas measurement

Publications (1)

Publication Number Publication Date
USD408917S true USD408917S (en) 1999-04-27

Family

ID=71727789

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/084,200 Expired - Lifetime USD408917S (en) 1998-02-26 1998-02-26 Membrane support structure of a flow through cell for blood gas measurement

Country Status (1)

Country Link
US (1) USD408917S (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
USD835783S1 (en) 2016-06-02 2018-12-11 Intarcia Therapeutics, Inc. Implant placement guide
US10159714B2 (en) 2011-02-16 2018-12-25 Intarcia Therapeutics, Inc. Compositions, devices and methods of use thereof for the treatment of cancers
US10231923B2 (en) 2009-09-28 2019-03-19 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US10363287B2 (en) 2005-02-03 2019-07-30 Intarcia Therapeutics, Inc. Method of manufacturing an osmotic delivery device
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US10441528B2 (en) 2008-02-13 2019-10-15 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US10501517B2 (en) 2016-05-16 2019-12-10 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
US10527170B2 (en) 2006-08-09 2020-01-07 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
US10835580B2 (en) 2017-01-03 2020-11-17 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CDI™ 400 Extracorporeal Blood Gas Monitoring System, Operator's Manual, CDI, 3M Health Care (In existence prior to Feb. 26, 1997).

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US10363287B2 (en) 2005-02-03 2019-07-30 Intarcia Therapeutics, Inc. Method of manufacturing an osmotic delivery device
US10527170B2 (en) 2006-08-09 2020-01-07 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
US10441528B2 (en) 2008-02-13 2019-10-15 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
US12042557B2 (en) 2009-09-28 2024-07-23 I2O Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US10231923B2 (en) 2009-09-28 2019-03-19 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US10869830B2 (en) 2009-09-28 2020-12-22 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US10159714B2 (en) 2011-02-16 2018-12-25 Intarcia Therapeutics, Inc. Compositions, devices and methods of use thereof for the treatment of cancers
US10583080B2 (en) 2014-09-30 2020-03-10 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
US10501517B2 (en) 2016-05-16 2019-12-10 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
US11214607B2 (en) 2016-05-16 2022-01-04 Intarcia Therapeutics Inc. Glucagon-receptor selective polypeptides and methods of use thereof
US11840559B2 (en) 2016-05-16 2023-12-12 I2O Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD912249S1 (en) 2016-06-02 2021-03-02 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) * 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD835783S1 (en) 2016-06-02 2018-12-11 Intarcia Therapeutics, Inc. Implant placement guide
US10835580B2 (en) 2017-01-03 2020-11-17 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
US11654183B2 (en) 2017-01-03 2023-05-23 Intarcia Therapeutics, Inc. Methods comprising continuous administration of exenatide and co-administration of a drug
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly

Similar Documents

Publication Publication Date Title
USD435089S (en) Faucet
USD408917S (en) Membrane support structure of a flow through cell for blood gas measurement
USD406299S (en) Float tube
USD388312S (en) Construction chair
USD402852S (en) Bowl
USD409750S (en) Flow through cell for blood gas measurement
USD427312S (en) Combined blood sampling device and meter
USD439538S1 (en) Fire detection system
USD379936S (en) Talking clinical thermometer
USD469864S1 (en) Capsule with expanded membrane
USD413044S (en) Cereal bowl
USD425274S (en) Housing
USD428499S (en) Retaining wall block with side openings
USD452331S1 (en) Tripod hunting stand
USD404649S (en) Water bottle
USD467665S1 (en) Test device
USD362387S (en) Liquid dropper
USD417087S (en) Stool
USD425975S (en) Humidifier
USD371189S (en) Gasket
USD395013S (en) Level
USD405354S (en) Tube
USD423244S (en) Seat
USD429177S (en) Indicating unit
USD407611S (en) Spoon